• Fund Type: SICAV
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

BlackRock Global Funds - World Healthscience Fund

+ Add to Watchlist

BGWRLX2:LX

33.09 USD 0.37 1.13%

As of 00:59:30 ET on 07/23/2014.

Snapshot for BlackRock Global Funds - World Healthscience Fund (BGWRLX2)

Year To Date: +12.05% 3-Month: +6.23% 3-Year: +20.91% 52-Week Range: 25.51 - 33.28
1-Month: +0.52% 1-Year: +25.36% 5-Year: - Beta vs NDWUHC: 1.07

Mutual Fund Chart for BGWRLX2

No chart data available.
  • BGWRLX2:LX 33.09
  • 1M
  • 1Y
Interactive BGWRLX2 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for BGWRLX2

BlackRock Global Funds - World Healthscience Fund is an open-end Fund incorporated in Luxembourg. The Fund's objective is to maximize growth in United States dollars. The Fund invests globally in equities of companies with substantial interests in healthcare, pharmaceuticals and medical technology and supplies.

Inception Date: 11-06-2009 Telephone: 352-34-20-101
Managers: THOMAS P CALLAN / H ERIN XIE
Web Site: www.blackrockinternational.com

Fundamentals for BGWRLX2

NAV (on 2014-07-23) 33.09
Assets (M) (on 2014-06-30) 2,374.10
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for BGWRLX2

No dividends reported

Fees & Expenses for BGWRLX2

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.00
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 0.06

Top Fund Holdings for BGWRLX2

Filing Date: 05/30/2014
Name Position Value % of Total
Johnson & Johnson 1,132,500 114,903,450 5.053%
Merck & Co Inc 1,682,900 97,372,594 4.282%
Novartis AG 984,800 88,460,697 3.890%
Roche Holding AG 273,300 80,557,693 3.543%
AbbVie Inc 1,469,500 79,837,935 3.511%
Biogen Idec Inc 223,700 71,443,069 3.142%
Pfizer Inc 2,374,200 70,347,546 3.094%
Bayer AG 459,000 66,453,449 2.923%
Alexion Pharmaceuticals Inc 390,168 64,892,742 2.854%
Celgene Corp 748,108 57,241,484 2.517%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil